Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1992 Feb;89(2):630–639. doi: 10.1172/JCI115629

Pathobiology of cast nephropathy from human Bence Jones proteins.

P W Sanders 1, B B Booker 1
PMCID: PMC442896  PMID: 1737851

Abstract

Renal failure is a common accompaniment of multiple myeloma and is usually due to cast nephropathy, or "myeloma kidney." To understand this lesion, four human Bence Jones proteins (BJP) were purified from the urine of volunteers who had either no evidence of renal dysfunction (BJP1) or renal failure from cast nephropathy (BJP2, BJP3, BJP4). When infused directly into the rat nephron in vivo, BJP2, BJP3, and BJP4 produced intraluminal obstruction by precipitating in the distal nephron; protein casts were never identified before the tip of the loop of Henle. Obstruction was related to the concentration of BJP in the perfusate. Addition of furosemide to the perfusate augmented obstruction in a concentration-dependent fashion. Pretreatment of rats with colchicine completely prevented obstruction and cast formation of perfused nephrons; beta-lumicolchicine did not prevent obstruction. Tamm-Horsfall glycoprotein purified from beta-lumicolchicine-treated and untreated rats coaggregated with BJP3 in vitro. Tamm-Horsfall glycoprotein from colchicine-treated rats did not contain sialic acid and did not aggregate with BJP3 in vitro. Thus, cast-forming human BJP coaggregated with Tamm-Horsfall glycoprotein and obstructed the rat distal nephron. Intranephronal obstruction was aggravated by decreasing extracellular fluid volume or adding furosemide. Finally, by decreasing secretion and altering the carbohydrate moiety of Tamm-Horsfall glycoprotein, colchicine prevented intraluminal cast formation and obstruction of the rat nephron.

Full text

PDF
630

Images in this article

633Image
on p.633
636Image
on p.636
637Image
on p.637
637Image
on p.637
637Image
on p.637
637Image
on p.637

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bachmann S., Metzger R., Bunnemann B. Tamm-Horsfall protein-mRNA synthesis is localized to the thick ascending limb of Henle's loop in rat kidney. Histochemistry. 1990;94(5):517–523. doi: 10.1007/BF00272616. [DOI] [PubMed] [Google Scholar]
  2. Bernstein S. P., Humes H. D. Reversible renal insufficiency in multiple myeloma. Arch Intern Med. 1982 Nov;142(12):2083–2086. [PubMed] [Google Scholar]
  3. Brunisholz M. C., Lynn K. L., Hunt J. S. Loop-acting diuretics do not bind to Tamm-Horsfall urinary glycoprotein. Clin Sci (Lond) 1987 Sep;73(3):305–310. doi: 10.1042/cs0730305. [DOI] [PubMed] [Google Scholar]
  4. Bryan C. W., McIntire K. R. Effect of sustained diuresis on the renal lesions of mice with Bence Jones protein-producing tumors. J Lab Clin Med. 1974 Mar;83(3):409–416. [PubMed] [Google Scholar]
  5. Burg M., Stoner L., Cardinal J., Green N. Furosemide effect on isolated perfused tubules. Am J Physiol. 1973 Jul;225(1):119–124. doi: 10.1152/ajplegacy.1973.225.1.119. [DOI] [PubMed] [Google Scholar]
  6. Clyne D. H., Pesce A. J., Thompson R. E. Nephrotoxicity of Bence Jones proteins in the rat: importance of protein isoelectric point. Kidney Int. 1979 Sep;16(3):345–352. doi: 10.1038/ki.1979.137. [DOI] [PubMed] [Google Scholar]
  7. Cohen A. H., Border W. A. Myeloma kidney. An immunomorphogenetic study of renal biopsies. Lab Invest. 1980 Feb;42(2):248–256. [PubMed] [Google Scholar]
  8. Dulawa J., Rambausek M., Jann K., Notohamiprodjo M., Ritz E. Abnormal radiofurosemide binding by Tamm Horsfall glycoprotein of diabetic patients. Diabetologia. 1985 Nov;28(11):827–830. doi: 10.1007/BF00291072. [DOI] [PubMed] [Google Scholar]
  9. EDELMAN G. M., GALLY J. A. The nature of Bence-Jones proteins. Chemical similarities to polypetide chains of myeloma globulins and normal gamma-globulins. J Exp Med. 1962 Aug 1;116:207–227. doi: 10.1084/jem.116.2.207. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Epstein W. V., Gulyassy P. F., Tan M., Rae A. I. Effect of renal hemotransplantation on the metabolism of the light chains of immunoglobulins. Ann Intern Med. 1968 Jan;68(1):48–62. doi: 10.7326/0003-4819-68-1-48. [DOI] [PubMed] [Google Scholar]
  11. Gutmann E. J., Niles J. L., McCluskey R. T., Brown D. Colchicine-induced redistribution of an apical membrane glycoprotein (gp330) in proximal tubules. Am J Physiol. 1989 Aug;257(2 Pt 1):C397–C407. doi: 10.1152/ajpcell.1989.257.2.C397. [DOI] [PubMed] [Google Scholar]
  12. Holland M. D., Galla J. H., Sanders P. W., Luke R. G. Effect of urinary pH and diatrizoate on Bence Jones protein nephrotoxicity in the rat. Kidney Int. 1985 Jan;27(1):46–50. doi: 10.1038/ki.1985.8. [DOI] [PubMed] [Google Scholar]
  13. Hoyer J. R., Seiler M. W. Pathophysiology of Tamm-Horsfall protein. Kidney Int. 1979 Sep;16(3):279–289. doi: 10.1038/ki.1979.130. [DOI] [PubMed] [Google Scholar]
  14. Kirchner K. A. Indomethacin antagonizes furosemide's intratubular effects during loop segment microperfusion. J Pharmacol Exp Ther. 1987 Dec;243(3):881–886. [PubMed] [Google Scholar]
  15. Kirchner K. A., Voelker J. R., Brater D. C. Intratubular albumin blunts the response to furosemide-A mechanism for diuretic resistance in the nephrotic syndrome. J Pharmacol Exp Ther. 1990 Mar;252(3):1097–1101. [PubMed] [Google Scholar]
  16. Kumar S., Muchmore A. Tamm-Horsfall protein--uromodulin (1950-1990). Kidney Int. 1990 Jun;37(6):1395–1401. doi: 10.1038/ki.1990.128. [DOI] [PubMed] [Google Scholar]
  17. Kyle R. A. Multiple myeloma: review of 869 cases. Mayo Clin Proc. 1975 Jan;50(1):29–40. [PubMed] [Google Scholar]
  18. MCINTIRE K. R., POTTER M. STUDIES OF THIRTY DIFFERENT BENCE JONES PROTEIN-PRODUCING PLASMA CELL NEOPLASMS IN AN INBRED STRAIN OF MOUSE. J Natl Cancer Inst. 1964 Oct;33:631–648. [PubMed] [Google Scholar]
  19. McQueen E. G. The nature of urinary casts. J Clin Pathol. 1962 Jul;15(4):367–373. doi: 10.1136/jcp.15.4.367. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Parczyk K., Haase W., Kondor-Koch C. Microtubules are involved in the secretion of proteins at the apical cell surface of the polarized epithelial cell, Madin-Darby canine kidney. J Biol Chem. 1989 Oct 5;264(28):16837–16846. [PubMed] [Google Scholar]
  21. Piasek A., Thyberg J. Effects of colchicine on endocytosis of horseradish peroxidase by rat peritoneal macrophages. J Cell Sci. 1980 Oct;45:59–71. doi: 10.1242/jcs.45.1.59. [DOI] [PubMed] [Google Scholar]
  22. SOLOMON A., FAHEY J. L. BENCE JONES PROTEINEMIA. Am J Med. 1964 Aug;37:206–222. doi: 10.1016/0002-9343(64)90006-3. [DOI] [PubMed] [Google Scholar]
  23. Sanders P. W., Booker B. B., Bishop J. B., Cheung H. C. Mechanisms of intranephronal proteinaceous cast formation by low molecular weight proteins. J Clin Invest. 1990 Feb;85(2):570–576. doi: 10.1172/JCI114474. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Sanders P. W., Herrera G. A., Chen A., Booker B. B., Galla J. H. Differential nephrotoxicity of low molecular weight proteins including Bence Jones proteins in the perfused rat nephron in vivo. J Clin Invest. 1988 Dec;82(6):2086–2096. doi: 10.1172/JCI113830. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Sanders P. W., Herrera G. A., Galla J. H. Human Bence Jones protein toxicity in rat proximal tubule epithelium in vivo. Kidney Int. 1987 Dec;32(6):851–861. doi: 10.1038/ki.1987.286. [DOI] [PubMed] [Google Scholar]
  26. Sanders P. W., Herrera G. A., Kirk K. A., Old C. W., Galla J. H. Spectrum of glomerular and tubulointerstitial renal lesions associated with monotypical immunoglobulin light chain deposition. Lab Invest. 1991 Apr;64(4):527–537. [PubMed] [Google Scholar]
  27. Sanders P. W., Herrera G. A., Lott R. L., Galla J. H. Morphologic alterations of the proximal tubules in light chain-related renal disease. Kidney Int. 1988 Apr;33(4):881–889. doi: 10.1038/ki.1988.80. [DOI] [PubMed] [Google Scholar]
  28. Smolens P., Venkatachalam M., Stein J. H. Myeloma kidney cast nephropathy in a rat model of multiple myeloma. Kidney Int. 1983 Aug;24(2):192–204. doi: 10.1038/ki.1983.144. [DOI] [PubMed] [Google Scholar]
  29. Solomon A. Bence-Jones proteins and light chains of immunoglobulins (first of two parts). N Engl J Med. 1976 Jan 1;294(1):17–23. doi: 10.1056/NEJM197601012940105. [DOI] [PubMed] [Google Scholar]
  30. Solomon A., Weiss D. T., Kattine A. A. Nephrotoxic potential of Bence Jones proteins. N Engl J Med. 1991 Jun 27;324(26):1845–1851. doi: 10.1056/NEJM199106273242603. [DOI] [PubMed] [Google Scholar]
  31. TAMM I., HORSFALL F. L., Jr Characterization and separation of an inhibitor of viral hemagglutination present in urine. Proc Soc Exp Biol Med. 1950 May;74(1):106–108. [PubMed] [Google Scholar]
  32. Tanner G. A., Evan A. P. Glomerular and proximal tubular morphology after single nephron obstruction. Kidney Int. 1989 Dec;36(6):1050–1060. doi: 10.1038/ki.1989.300. [DOI] [PubMed] [Google Scholar]
  33. Valberg P. A., Brain J. D., Kane D. Effects of colchicine or cytochalasin B on pulmonary macrophage endocytosis in vivo. J Appl Physiol Respir Environ Exerc Physiol. 1981 Mar;50(3):621–629. doi: 10.1152/jappl.1981.50.3.621. [DOI] [PubMed] [Google Scholar]
  34. Weiss J. H., Williams R. H., Galla J. H., Gottschall J. L., Rees E. D., Bhathena D., Luke R. G. Pathophysiology of acute Bence-Jones protein nephrotoxicity in the rat. Kidney Int. 1981 Aug;20(2):198–210. doi: 10.1038/ki.1981.122. [DOI] [PubMed] [Google Scholar]
  35. Woodruff R., Sweet B. Multiple myeloma with massive Bence Jones proteinuria and preservation of renal function. Aust N Z J Med. 1977 Feb;7(1):60–62. doi: 10.1111/j.1445-5994.1977.tb03359.x. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES